OPEN-SOURCE SCRIPT
Custom MACD (Normalized by ATR)

This is a modified version of the classic MACD indicator.
Instead of using just the difference between EMA(12) and EMA(26), this version normalizes the MACD line by ATR(26) and scales it by 100:
[(EMA12 - EMA26)/(26 ATR)] * 100
This adjustment makes the MACD relative to market volatility, allowing for easier comparison across assets and timeframes.
The idea of normalizing MACD with ATR comes from Alex Spioglou, who suggested this improvement to enhance signal consistency in volatile markets.
Plots include the ATR-normalized MACD line, the signal line, and the histogram, with rising/falling color cues and built-in alert conditions.
Instead of using just the difference between EMA(12) and EMA(26), this version normalizes the MACD line by ATR(26) and scales it by 100:
[(EMA12 - EMA26)/(26 ATR)] * 100
This adjustment makes the MACD relative to market volatility, allowing for easier comparison across assets and timeframes.
The idea of normalizing MACD with ATR comes from Alex Spioglou, who suggested this improvement to enhance signal consistency in volatile markets.
Plots include the ATR-normalized MACD line, the signal line, and the histogram, with rising/falling color cues and built-in alert conditions.
Open-source script
In true TradingView spirit, the creator of this script has made it open-source, so that traders can review and verify its functionality. Kudos to the author! While you can use it for free, remember that republishing the code is subject to our House Rules.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Open-source script
In true TradingView spirit, the creator of this script has made it open-source, so that traders can review and verify its functionality. Kudos to the author! While you can use it for free, remember that republishing the code is subject to our House Rules.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.